基于MRI同反相位序列衍生的脂质分数作为预测胶质瘤生存结局的新型生物标志物
研究纳入46例组织学证实的胶质瘤(WHO II-IV级)患者,采用3T MRI同反相位序列计算脂质分数,按受试者工作特征曲线下体积三分组分析。低、中、高脂质分数组在总生存期和至进展时间上差异显著(p≤0.01),高脂质分数组死亡风险为低脂质分数组的5倍且进展更早,脂质分数分层与WHO分级分层的总生存曲线强相关(R=0.61,p<0.01)。
要点
- 脂质分数由同反相位序列信号丢失率计算,取自胶质瘤实性非强化区。
- 按最佳截断值分为低、中、高脂质分数三组,总生存期与至进展时间组间差异显著(p≤0.01)。
- 高脂质分数组较低脂质分数组死亡风险高5倍且至进展时间更早。
核心结论
- 胶质瘤实性非强化区的脂质分数显示出预测预后的潜力,该方法可作为治疗方案分层影像协议的有用辅助手段及胶质瘤患者的预后工具。
研究设计与样本
- 研究分析了46例组织学证实的胶质瘤(WHO II-IV级)患者,使用标准3T MRI脑肿瘤协议及同反相位序列,以同反相位序列信号丢失率衍生脂质分数,采用基于受试者工作特征曲线下体积的三组分析方法将预后因素分为低、中、高脂质分数三组,用Kaplan-Meier生存分析和Cox回归模型评估生存结局。
诊断标准与关键数值
- 脂质分数由同反相位序列信号丢失率衍生,分析区域为胶质瘤实性非强化区,基于受试者工作特征曲线下体积的三组分析方法按最佳截断值将患者分为低、中、高脂质分数组,用于总生存期和至进展时间的分层。
临床应用与阅片要点
- 作者认为该方法将成为胶质瘤治疗方案分层影像协议的有用辅助手段及预后工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND PURPOSE: Our study evaluated the capability of magnetic resonance imaging in- and opposed-phase (IOP) derived lipid fraction as a novel prognostic biomarker of survival outcome in glioma.
MATERIALS AND METHODS: We analyzed 46 histologically proven glioma (WHO grades II-IV) patients using standard 3T magnetic resonance imaging brain tumor protocol and IOP sequence. Lipid fraction was derived from the IOP sequence signal-loss ratio. The lipid fraction of solid nonenhancing region of glioma was analyzed, using a three-group analysis approach based on volume under surface of receiver-operating characteristics to stratify the prognostic factors into three groups of low, medium, and high lipid fraction. The survival outcome was evaluated, using Kaplan-Meier survival analysis and Cox regression model.
RESULTS: Significant differences were seen between the three groups (low, medium, and high lipid fraction groups) stratified by the optimal cut-off point for overall survival (OS) (p ≤ 0.01) and time to progression (p ≤ 0.01) for solid nonenhancing region. The group with high lipid fraction had five times higher risk of poor survival and earlier time to progression compared to the low lipid fraction group. The OS plot stratified by lipid fraction also had a strong correlation with OS plot stratified by WHO grade (R = 0.61, p < 0.01), implying association to underlying histopathological changes.
CONCLUSION: The lipid fraction of solid nonenhancing region showed potential for prognostication of glioma. This method will be a useful adjunct in imaging protocol for treatment stratification and as a prognostic tool in glioma patients.
引用
- Seow P, Narayanan V, Romelean RJ, et al. Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma. Acad Radiol. 2019. PMID: 31155487. doi:10.1016/j.acra.2019.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。